Financials · Property & Casualty Insurance · US stock · price as of 16 Oct 2026
Key indicators
Price
$389.54
52-week range
$248.46 – $397.34
Market cap
$82.0B
P/E (trailing)
10.2×
Dividend yield
1.2%
Revenue (last 12 months)
$48.9B
Revenue growth (3y a year)
9.8%
Price / book
2.8×
Return on equity
28.7%
Fair value
Blended fair value$271.68 book-value models
Versus priceOvervalued−30% to fair value
Excess-return model (banks, insurers)
$209.68
Price / book vs return on equity
$364.69
Model uncertainty
High
X-Ray Score
54/ 100 · Medium confidence · ahead of 68% of sector peers
Valuation49
Growth55
Profitability65
Financial health49
Dividends44
Five-year price chart navy: price · brown: 200-day average · blue band: fair value range
Executive summary
Travelers is a property and casualty insurer that sells commercial and personal coverage in the United States and in some other markets. Products include business insurance, bonds, auto, homeowners and specialty lines, sold largely through independent agents and brokers. Revenue comes from premiums paid by policyholders and from investment income earned on the premiums it holds before claims are paid, with results affected by weather and claim costs.
Revenue over the last twelve months came to $48.9 billion. Across three years, revenue grew 9.8% a year. It posts an operating margin of 22.1%, with return on invested capital of 31%. The dividend yield is 1.2%. These figures describe past results as reported and are a factual snapshot, not a forecast. Some measures, such as margins for real estate trusts and banks, are defined differently from those of industrial firms, so comparisons should be made with care.
StocksXray gives Travelers Companies, Inc. an X-Ray Score of 54 out of 100 (medium confidence), ahead of 68% of the S&P 500 stocks in its sector. Its strongest lens is profitability (65) and its weakest is dividends (44).
Our fair value blend is $271.68. At $389.54 the stock trades 43% above that blend, so the label is "Overvalued" with high model uncertainty. Fair value is a range, not a price target.
XStocksXray
Travelers Companies, Inc. (TRV)
Valuation history multiples at each fiscal year-end price; the last column uses today's price and the last twelve months
FY2021
FY2022
FY2023
FY2024
FY2025
Now
Price
$143.07
$175.15
$182.03
$234.38
$286.82
$389.54
Market cap
$35.9B
$42.0B
$42.3B
$54.2B
$65.3B
$82.0B
P/E
9.9×
14.9×
14.2×
10.9×
10.5×
10.2×
Price / book
1.2×
1.9×
1.7×
1.9×
2.0×
2.8×
Dividend yield
–
–
–
–
–
1.21%
Fundamentals checklist ● 2 Good · ● 3 Average · ● 2 Bad · each check graded against the sector
Risk models
Piotroski F-Score7 of 9Average
Growth
EPS growth (3y)32.6%Good
Revenue growth (3y)9.8%Average
Growth consistency90%Average
Valuation
Fair value vs price0.7×Bad
Profitability
Return on invested capital30.8%Good
Operating margin22.1%Bad
XStocksXray
Travelers Companies, Inc. (TRV)
Financials US$ millions, from SEC filings; last column is the last twelve months
Income statement
FY21
FY22
FY23
FY24
FY25
LTM
Revenue
34,816
36,884
41,364
46,423
48,828
48,921
Net income
3,662
2,842
2,991
4,999
6,288
8,332
Diluted EPS ($)
14.49
11.77
12.79
21.47
27.43
38.30
Net margin
10.5%
7.7%
7.2%
10.8%
12.9%
17.0%
Balance sheet
FY21
FY22
FY23
FY24
FY25
LTM
Total assets
120,466
115,717
125,978
133,189
143,708
142,089
Cash
761
799
650
699
842
766
Total debt
200
200
200
200
400
–
Equity
28,887
21,560
24,921
27,864
32,894
28,995
Dividend per share ($)
–
–
–
–
–
–
Revenue and net income US$ billions: navy revenue, teal net income
Every number comes from SEC filings, end-of-day prices and the StocksXray models described on the methodology page. The X-Ray Score ranks each metric against the company's own sector. Fair value blends three models and carries a typical error of about 40%, so treat it as a range. Analyst ratings, price targets and earnings-call summaries are not part of this report. Educational research, not financial advice; read the disclaimer.